Skip to main content
. 2021 May 6;42(8):3071–3077. doi: 10.1007/s10072-021-05282-3

Table 2.

Patient demographics and BT therapy data

Total number of patients [n] 25
Male patients [n] 16
Female patients [n] 9
Patient age (mean ± standard deviation) [years] 19.8 ± 7.9
Indication for BT therapy Complications of CP
BT drug OnabotulinumtoxinA
BT total equivalent dose in 2020 (mean ± standard deviation) [IU] 180 ± 88.32
Treatment duration (mean ± standard deviation) [years] 3.4 ± 1.7
Interinjection interval before lockdown (mean ± standard deviation) [months] 5 ± 1.8